news
NHS releases guidance to remove drugs from prescription list
Seven medications have been suggested for removal from prescriptions by the NHS after a public consultation.
List view / Grid view
Diabetes
news
Revealed structure of glucagon fibrils could improve drug formulation
Researchers have discovered the formulation of glucagon fibrils, which could inform drug formulation for diabetic patients.
news
Global diabetes drug market expected to rise 3.6 percent
A new report predicts that the global diabetes drug market will rise to US$58.4 billion by 2025.
news
Job cuts limit cardiovascular and diabetes research and development
Pharmaceutical company, Sanofi, will eliminate jobs in France and Germany and end new in-house cardiology research programmes.
news
API markets to grow 6.8 percent by 2026
Global active pharmaceutical ingredients market set to surpass US$274.9 billion by 2026.
news
British Columbia first province to switch patients to biosimilars
British Columbia has said it will switch as many as 20,400 patients from three branded biologic drugs to cheap biosimilars.
news
Report shows US brand-name drug prices ‘highest in the world’
A new study has found that prices for brand-name prescription drugs averaged 3.2 to 4.1 times higher in the US compared with other countries.
news
Ready-to-use glucagon for exercise-induced hypoglycaemia
This study will evaluate the ready-to-use, room-temperature stable liquid glucagon as a pre-treatment to prevent exercise-induced hypoglycemia...
news
Statins might be linked to increased risk of diabetes
Researchers have identified a possible association between use of statins and developing type 2 diabetes after following patients for 15 years...
news
Lilly introduces cheaper generic insulin in the US
The generic version will cost 50 percent less that the current Humalog list price...
news
Compressed injection pill for oral insulin delivery
A compressed injection pill could be the future alternative to injections of insulin delivery for patients with type 2 diabetes...
news
Committee demands answers on rising cost of insulin in the US
Letters have been sent to Eli Lilly, Novo Nordisk and Sanofi asking them to explain the rapidly increasing cost of insulin...
news
Canagliflozin may not be associated with fracture risk in diabetes patients
A study has found that when compared with other drugs, canagliflozin may not be associated with fractures in patients with diabetes...
news
Big Data and AI provide better diagnosis and treatment
MedUni Vienna researchers have developed a way to use retinal imaging to diagnose diabetes, explaining how the technique could be used for other conditions...
news
Insulin supply chain transparency needed to prevent price hikes
The Endocrine Society has reported that increasing costs of insulin means that people are often deciding to forgo necessary treatment...
